0001144204-19-030608.txt : 20190611 0001144204-19-030608.hdr.sgml : 20190611 20190611175108 ACCESSION NUMBER: 0001144204-19-030608 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190607 FILED AS OF DATE: 20190611 DATE AS OF CHANGE: 20190611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van der Velden Peter CENTRAL INDEX KEY: 0001778046 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 19891952 MAIL ADDRESS: STREET 1: C/O EDESA BIOTECH INC. STREET 2: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lumira Capital Investment Management Inc. CENTRAL INDEX KEY: 0001702636 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 19891953 BUSINESS ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 BUSINESS PHONE: 416-213-4223 MAIL ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 BUSINESS PHONE: (805) 488-2800 MAIL ADDRESS: STREET 1: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 3 1 tv523427_3.xml OWNERSHIP DOCUMENT X0206 3 2019-06-07 1 0001540159 Edesa Biotech, Inc. EDSA 0001778046 van der Velden Peter C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA 1 0 1 0 0001702636 Lumira Capital Investment Management Inc. 141 ADELAIDE STREET WEST, SUITE 770 TORONTO A6 M5H 3L5 ONTARIO, CANADA 0 0 1 0 This Form 3 is jointly filed by (i) Lumira Capital II, L.P., (ii) Lumira Capital II (International), L.P., (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co. and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of Lumira Capital II, L.P. and Lumira Capital II (International), L.P., and each of Lumira Capital II, L.P. and Lumira Capital II (International), L.P. is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc. Lumira GP Holdings Co. and Lumira Capital Investment Management Inc. Therefore, each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own shares of the Issuer held by Lumira Capital II, L.P. and Lumira Capital II (International), L.P. /s/ Peter van der Velden 2019-06-11 LUMIRA CAPITAL INVESTMENT MANAGEMENT INC., /s/ Vasco Larcina, VP Finance 2019-06-11